COVID-19 Road to a vaccine

The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-CoV-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.



Associate Professor Nigel Crawford
Director, Melbourne Vaccine Education Centre

A/Prof Crawford is a consultant paediatrician and vaccinologist. He is also Director of SAEFVIC based at Murdoch Children’s Research Institute (MCRI) and Head of Immunisation Services at The Royal Children’s Hospital (RCH).

He is an expert in the vaccination of special risk groups, a member of ATAGI COVID-19 Working Group Executive, Chair of ATAGI Subgroup #3 (Vaccine Safety, Evaluation & Confidence / Communication), Chair of ATAGI Meningococcal and Special Risk Working Groups on Immunisation, Chair of Vaccine Safety Committee (B Part of It NT study), and Member of SA Health Men B Vaccine Safety Advisory Board.